| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (Drs. Bressman, Raymond, and de Leon), Beth Israel Medical Center, New York, NY; the Department of Neurology (Dr. Bressman), Albert Einstein College of Medicine, Bronx, NY; the Department of Genetics (Drs. Sabatti and Risch), Stanford University, Stanford, CA; the Molecular Neurogenetics Unit (Drs. Klein, Breakefield, and Ozelius), Neurology Service, Massachusetts General Hospital and Department of Neurology and Genetics, Harvard Medical School, Boston; the Department of Neurology (Dr. Kramer), Oregon Health Sciences University, Portland; the Department of Neurology (Dr. Brin), Mt. Sinai Hospital, New York, NY; and the Department of Neurology (Dr. Fahn), Columbia Presbyterian Medical Center, New York, NY.
Address correspondence and reprint requests to Dr. S.B. Bressman, Beth Israel Medical Center, 10 Union Square East, Department of Neurology, Suite 2R, New York, NY 10003.
OBJECTIVE: To develop diagnostic testing guidelines for the DYT1 GAG deletion in the Ashkenazi Jewish (AJ) and non-Jewish (NJ) primary torsion dystonia (PTD) populations and to determine the range of dystonic features in affected DYT1 deletion carriers.
METHODS: The authors screened 267 individuals with PTD; 170 were clinically ascertained for diagnosis and treatment, 87 were affected family members ascertained for genetic studies, and 10 were clinically and genetically ascertained and included in both groups. We used published primers and PCR amplification across the critical DYT1 region to determine GAG deletion status. Features of dystonia in clinically ascertained (affected) DYT1 GAG deletion carriers and noncarriers were compared to determine a classification scheme that optimized prediction of carriers. The authors assessed the range of clinical features in the genetically ascertained (affected) DYT1 deletion carriers and tested for differences between AJ and NJ patients.
RESULTS: The optimal algorithm for classification of clinically ascertained carriers was disease onset before age 24 years in a limb (misclassification, 16.5%; sensitivity, 95%; specificity, 80%). Although application of this classification scheme provided good separation in the AJ group (sensitivity, 96%; specificity, 88%), as well as in the group overall, it was less specific in discriminating NJ carriers from noncarriers (sensitivity, 94%; specificity, 69%). Using age 26 years as the cut-off and any site at onset gave a sensitivity of 100%, but specificity decreased to 54% (63% in AJ and 43% in NJ). Among genetically ascertained carriers, onset up to age 44 years occurred, although the great majority displayed early limb onset. There were no significant differences between AJ and NJ genetically ascertained carriers, except that a higher proportion of NJ carriers had onset in a leg, rather than an arm, and widespread disease.
CONCLUSIONS: Diagnostic DYT1 testing in conjunction with genetic counseling is recommended for patients with PTD with onset before age 26 years, as this single criterion detected 100% of clinically ascertained carriers, with specificities of 43% to 63%. Testing patients with onset after age 26 years also may be warranted in those having an affected relative with early onset, as the only carriers we observed with onset at age 26 or later were genetically ascertained relatives of individuals whose symptoms started before age 26 years.
Key words: Dystonia—DYT1—Genetic testing
This article has been cited by other articles:
|
|
 |
|
  C. Kamm, H. Fischer, B. Garavaglia, S. Kullmann, M. Sharma, C. Schrader, K. Grundmann, C. Klein, I. Borggrafe, E. Lobsien, et al. SUSCEPTIBILITY TO DYT1 DYSTONIA IN EUROPEAN PATIENTS IS MODIFIED BY THE D216H POLYMORPHISM Neurology, June 3, 2008; 70(23): 2261 - 2262. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Yokoi, M. T. Dang, S. Mitsui, J. Li, and Y. Li Motor Deficits and Hyperactivity in Cerebral Cortex-specific Dyt1 Conditional Knockout Mice J. Biochem., January 1, 2008; 143(1): 39 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Defazio, A. Berardelli, and M. Hallett Do primary adult-onset focal dystonias share aetiological factors? Brain, May 1, 2007; 130(5): 1183 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. Chinnery, D. E. Crompton, D. Birchall, M. J. Jackson, A. Coulthard, A. Lombes, N. Quinn, A. Wills, N. Fletcher, J. P. Mottershead, et al. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation Brain, January 1, 2007; 130(1): 110 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tarsy and D. K. Simon Dystonia N. Engl. J. Med., August 24, 2006; 355(8): 818 - 829. [Full Text] [PDF]
|
|
|
|
|
|
P. E. Greene, W. Dauer, and V. Wong Stiff child syndrome with mutation of DYT1 gene Neurology, May 9, 2006; 66(9): 1456 - 1456. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kock, T. V. Naismith, H. E. Boston, L. J. Ozelius, D. P. Corey, X. O. Breakefield, and P. I. Hanson Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier Hum. Mol. Genet., April 15, 2006; 15(8): 1355 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. C.N. Wong, C.-W. Lam, and C. W. Fung Stiff child syndrome with mutation of DYT1 gene Neurology, November 8, 2005; 65(9): 1465 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vidailhet, L. Vercueil, J.-L. Houeto, P. Krystkowiak, A.-L. Benabid, P. Cornu, C. Lagrange, S. Tezenas du Montcel, D. Dormont, S. Grand, et al. Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized Dystonia N. Engl. J. Med., February 3, 2005; 352(5): 459 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. O'Riordan, D. Raymond, T. Lynch, R. Saunders-Pullman, S. B. Bressman, L. Daly, and M. Hutchinson Age at onset as a factor in determining the phenotype of primary torsion dystonia Neurology, October 26, 2004; 63(8): 1423 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Heiman, R. Ottman, R. J. Saunders-Pullman, L. J. Ozelius, N. J. Risch, and S. B. Bressman Increased risk for recurrent major depression in DYT1 dystonia mutation carriers Neurology, August 24, 2004; 63(4): 631 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Detante, L. Vercueil, S. Thobois, E. Broussolle, N. Costes, F. Lavenne, S. Chabardes, D. Lebars, M. Vidailhet, A.-L. Benabid, et al. Globus pallidus internus stimulation in primary generalized dystonia: a H215O PET study Brain, August 1, 2004; 127(8): 1899 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kamm, H. Boston, J. Hewett, J. Wilbur, D. P. Corey, P. I. Hanson, V. Ramesh, and X. O. Breakefield The Early Onset Dystonia Protein TorsinA Interacts with Kinesin Light Chain 1 J. Biol. Chem., May 7, 2004; 279(19): 19882 - 19892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kabakci, K. Hedrich, J. C. Leung, M. Mitterer, P. Vieregge, R. Lencer, J. Hagenah, J. Garrels, K. Witt, F. Klostermann, et al. Mutations in DYT1: Extension of the phenotypic and mutational spectrum Neurology, February 10, 2004; 62(3): 395 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Grundmann, U. Laubis-Herrmann, I. Bauer, D. Dressler, J. Vollmer-Haase, P. Bauer, M. Stuhrmann, T. Schulte, L. Schols, H. Topka, et al. Frequency and Phenotypic Variability of the GAG Deletion of the DYT1 Gene in an Unselected Group of Patients With Dystonia Arch Neurol, September 1, 2003; 60(9): 1266 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Anca, Tcipora Falik Zaccai, S. Badarna, A. M. Lozano, A. E. Lang, and N. Giladi Natural History of Oppenheim's Dystonia (DYT1) in Israel J Child Neurol, May 1, 2003; 18(5): 325 - 330. [Abstract] [PDF]
|
|
|
|
|
|
S. B. Bressman, D. Raymond, K. Wendt, R. Saunders-Pullman, D. de Leon, S. Fahn, L. Ozelius, and N. Risch Diagnostic criteria for dystonia in DYT1 families Neurology, December 10, 2002; 59(11): 1780 - 1782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Nemeth The genetics of primary dystonias and related disorders Brain, April 1, 2002; 125(4): 695 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tuffery-Giraud, L. Cavalier, A. Roubertie, C. Guittard, S. Carles, P. Calvas, B. Echenne, P. Coubes, and M. Claustres No evidence of allelic heterogeneity in the DYT1 gene of European patients with early onset torsion dystonia J. Med. Genet., October 1, 2001; 38 (10): e35 - e35. [Full Text] [PDF]
|
|
|
|
|
|
S. B. Bressman, S. Fahn, L. J. Ozelius, P. L. Kramer, N. J. Risch, A. Durr, D. Brassat, M. Vidailhet, and A. Brice The DYT1 Mutation and Nonfamilial Primary Torsion Dystonia Arch Neurol, April 1, 2001; 58(4): 681 - 682. [Full Text] [PDF]
|
|
|
|
|
|
D. G. Lichter and A. E. Lang To test or not to test?: That is the question (with a twist) Neurology, May 9, 2000; 54(9): 1718 - 1719. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
